Developmental studies in a pig model with any two generally-null alleles could be translated directly to patients for non allele-specific treatments of PKU, such as oral administration of supplements, probiotics, dietary control of circulating phenylalanine, and gene delivery of PAH or phenylalanine ammonia-lyase (PAL). Here, PAH is linked to phenylketonuria.